Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol in elderly hip replacement anesthesia
ChiCTR2100055039Phase 4Recruiting
- Sponsor
- Hefei Second People's Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Rapidly Destructive Coxarthrosis (RDC), hip osteoarthritis, osteonecrosis of the hip and 1 more comparing Remimazolam group with Propofol group (2 arms). Primary endpoints: Circulation indicators, Stress indicators and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Rapidly Destructive Coxarthrosis (RDC)hip osteoarthritisosteonecrosis of the hipNeck Of Femur Fracture
Beyond the preview
Go deeper on ChiCTR2100055039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100055039.